Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis-Reference-Cited by-同舟云学术

Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis

Published:2010-08-30 Issue:1 Volume:117 Page:162-174
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pallini Roberto,Ricci-Vitiani Lucia,Montano Nicola,Mollinari Cristiana,Biffoni Mauro,Cenci Tonia,Pierconti Francesco,Martini Maurizio,De Maria Ruggero,Larocca Luigi Maria

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. European Organization for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med.,2005

2. Identification of a cancer stem cell in human brain tumors;Singh;Cancer Res.,2003

3. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma;Galli;Cancer Res.,2004

4. Identification of brain tumor initiating cells;Singh;Nature.,2004

5. Development of gliomas: potential role of asymmetrical cell division of neural stem cells;Berger;Lancet Oncol.,2004

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Clinical Success and Molecular Mechanisms of Action of Novel Anti-glioblastoma Drugs: A Review;Current Medicinal Chemistry;2024-01-30

2. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons;International Journal of Molecular Sciences;2023-12-12

3. Leveraging intracellular ALDH1A1 activity for selective cancer stem-like cell labeling and targeted treatment via in vivo click reaction;Proceedings of the National Academy of Sciences;2023-08-28

4. Systems Medicine for Precise Targeting of Glioblastoma;Molecular Biotechnology;2023-03-01

5. Protein CD133 as a tumor stem cell marker;Voprosy neirokhirurgii imeni N.N. Burdenko;2022